Analysis of novel mutations in triple negative breast cancer using NGS
Project/Area Number |
25461982
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
General surgery
|
Research Institution | Shokei University |
Principal Investigator |
Kariu Toru 尚絅大学, 生活科学部, 准教授 (10412735)
|
Co-Investigator(Kenkyū-buntansha) |
IMAMURA Takahisa 熊本大学, 大学院生命科学研究部, 准教授 (20176499)
|
Project Period (FY) |
2013-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2015: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2014: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2013: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
|
Keywords | 乳がん / エキソーム解析 |
Outline of Final Research Achievements |
Breast cancer is categolized into three groups according to expressions of either of ER, progesterone receptor, and HERS. To under stand and develop effective therapeutic agents against the triple negative brest cancer, we identified a correlation of the expression of anaphylatoxin receptor with cancer prognosis.
|
Report
(4 results)
Research Products
(2 results)